Cargando…
Retraction Note to: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108323/ https://www.ncbi.nlm.nih.gov/pubmed/33971879 http://dx.doi.org/10.1186/s12935-021-01958-0 |
_version_ | 1783690108476588032 |
---|---|
author | Hu, Yang Xie, Hong Liu, Yankun Liu, Weiying Liu, Min Tang, Hua |
author_facet | Hu, Yang Xie, Hong Liu, Yankun Liu, Weiying Liu, Min Tang, Hua |
author_sort | Hu, Yang |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8108323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81083232021-05-11 Retraction Note to: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells Hu, Yang Xie, Hong Liu, Yankun Liu, Weiying Liu, Min Tang, Hua Cancer Cell Int Retraction Note BioMed Central 2021-05-10 /pmc/articles/PMC8108323/ /pubmed/33971879 http://dx.doi.org/10.1186/s12935-021-01958-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Retraction Note Hu, Yang Xie, Hong Liu, Yankun Liu, Weiying Liu, Min Tang, Hua Retraction Note to: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells |
title | Retraction Note to: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells |
title_full | Retraction Note to: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells |
title_fullStr | Retraction Note to: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells |
title_full_unstemmed | Retraction Note to: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells |
title_short | Retraction Note to: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells |
title_sort | retraction note to: mir-484 suppresses proliferation and epithelial–mesenchymal transition by targeting zeb1 and smad2 in cervical cancer cells |
topic | Retraction Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108323/ https://www.ncbi.nlm.nih.gov/pubmed/33971879 http://dx.doi.org/10.1186/s12935-021-01958-0 |
work_keys_str_mv | AT huyang retractionnotetomir484suppressesproliferationandepithelialmesenchymaltransitionbytargetingzeb1andsmad2incervicalcancercells AT xiehong retractionnotetomir484suppressesproliferationandepithelialmesenchymaltransitionbytargetingzeb1andsmad2incervicalcancercells AT liuyankun retractionnotetomir484suppressesproliferationandepithelialmesenchymaltransitionbytargetingzeb1andsmad2incervicalcancercells AT liuweiying retractionnotetomir484suppressesproliferationandepithelialmesenchymaltransitionbytargetingzeb1andsmad2incervicalcancercells AT liumin retractionnotetomir484suppressesproliferationandepithelialmesenchymaltransitionbytargetingzeb1andsmad2incervicalcancercells AT tanghua retractionnotetomir484suppressesproliferationandepithelialmesenchymaltransitionbytargetingzeb1andsmad2incervicalcancercells |